Immunogenicity and safety evaluation of a newly manufactured recombinant Baculovirus-Expressed quadrivalent influenza vaccine in adults 18 years old and Above: An Open-Label, phase III extension study
-
Published:2024-07
Issue:
Volume:136
Page:112214
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Shahri Mohammad Saleh,
Sadeghi Setayesh,
Hazegh Fetratjoo Delara,
Hosseini Hamed,
Amin Ghobadi Mohammad,
Afshani Seyyedeh Maryam,
Mirhassani ReihanehORCID,
Gohari Kimiya,
Havasi Forugh,
Abdolghaffari Amirhossein,
Hedayatjoo Behnaz,
Ghanei MostafaORCID